PL BioScience GmbH develops ELAREM™ Human Platelet Lysate platform, delivering xeno-free cell culture supplements rich in natural growth factors. Their HPL products support expansion of stem and immune cells, offering GMP-ready alternatives that outperform fetal bovine serum for regenerative medicine and cell therapy.
Looking for a particular PL BioScience GmbH employee's phone or email?
The PL BioScience GmbH annual revenue was $4 million in 2026.
Hatim Hemeda is the CEO and Founder of PL BioScience GmbH.
20 people are employed at PL BioScience GmbH.
PL BioScience GmbH is based in Aachen, North Rhine-Westphalia.
The NAICS codes for PL BioScience GmbH are [54, 54171, 5417, 541713, 541].
The SIC codes for PL BioScience GmbH are [873, 87].